I Failed to Realize That!: Top Twelve Chlormezanone Of The Year

At the initiation https://en.wikipedia.org/wiki/Chlormezanone of veno-venous ECMO, the patient was severely neutropenic (leucocytes http://www.selleckchem.com/products/Nolvadex.html to the high-risk arm of the ALL-BFM 2000 protocol with induction therapy and six high-risk intensified consolidation blocks as previously published (Moricke et?al, 2008). Following this therapy, histologically proven pulmonary mucormycosis was diagnosed and further chemotherapy had to be postponed for three months. After 2?months of combined antimycotic therapy with liposomal amphotericin (Abelcet?, http://www.selleckchem.com/products/Fludarabine(Fludara).html Cephalon GmbH, Martinsried, Germany) and posaconazole (Noxafil?, SP Europe, Bruxelle, Belgium), one residual nodular lesion was resected thoracoscopically. Three weeks after starting reinduction therapy with dexamethasone (10?mg/m2) on days 1�C21, weekly vincristine (1��5?mg/m2) on days 8, 15 and 22, doxorubicin (30?mg/m2) on days 8 and 15, and pegylated Asparaginase (1000?U/m2) on day 8, this patient developed E.?coli sepsis, bilateral pneumonia and multiple cerebral lesions. After he developed ARDS, which failed to respond to conventional ventilation and oscillation, veno-venous ECMO was commenced. Five doses (5?��g/kg per day) of G-CSF (Neupogen?) were administered for treatment of neutropenia. During the 15-d ECMO support this patient required massive blood component transfusions including one fresh frozen plasma, 31 packed red blood cells, 54 apheresis platelet concentrates and 4 cryoprecipitates. Nevertheless his clinical course was complicated by apparent episodes of pulmonary bleeding and no improvement of pulmonary gas exchange. He died 15?d after initiation of ECMO treatment because of unmanageable chronic bleeding into both lungs. Postmortem examination revealed severe haemorrhagic ARDS of both lungs with haemorrhagic destruction of lung tissue (Fig?3A, B).